Logo

Rosetta Green Licenses microRNA from Iowa State

Aug 16, 2012
Premium

Rosetta Green said this week that it has signed an agreement under which it licensed an undisclosed microRNA from Iowa State University for use in developing plants resistant to nematodes.

Specific terms of the deal were not disclosed.

“Nematode worms are an increasing worldwide problem due to the lack of measures against this pest,” Rosetta Green CEO Amir Avniel said in a statement. “We see once again the potential of microRNA genes to improve plant traits.”

Filed under

Gene Editing, Gene Silencing, & CRISPR
Business News
licensing agreement
Iowa State
RNAi
miRNA
Rosetta Green
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.